{"id":"W2078126254","doi":"10.2174/1381612013397401","title":"Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes","year":2001,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Glucagon-like peptide-2; Incretin; Glucagon-like peptide-1; Enteroendocrine cell; Receptor; Glucagon-like peptide 1 receptor; In vivo; Endocrinology; Pharmacology; Diabetes mellitus; Internal medicine; Medicine; Biology; Endocrine system; Type 2 diabetes; Hormone; Biochemistry; Peptide; Agonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003231764,0.0005805867,0.0005650516,0.0007081699,0.0001259728,0.0006590686,0.0003960287,0.0007498905,0.002377952],"category_scores_gemma":[0.0002579668,0.0002438591,0.0004683488,0.0004488702,0.0001756752,0.0007452516,0.0004348325,0.001219786,0.001674305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003155786,"about_ca_system_score_gemma":0.0003497892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002360845,"about_ca_topic_score_gemma":0.0004162972,"domain_scores_codex":[0.9998742,0.00002349505,0.00001250492,0.00002274791,0.00004787914,0.00001902177],"domain_scores_gemma":[0.9999412,0.00001367192,0.00001435336,0.000002695284,0.00001648818,0.00001163106],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003103553,0.0002461712,0.0002407819,0.009227836,0.0001601377,0.0008744394,0.0001128988,0.001518396,0.2295719,0.01330366,0.01456525,0.7298682],"study_design_scores_gemma":[0.0001497726,0.001495281,0.001173537,0.0009743827,0.0002246417,0.002285378,0.00004604632,0.001152753,0.05206675,0.00381778,0.9365543,0.00005949734],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008224918,0.9709093,0.008052128,0.0007892208,0.0009142649,0.00008874337,0.0002135111,0.0001086635,0.01069917],"genre_scores_gemma":[0.03613945,0.9451221,0.009625256,0.001037489,0.0005541029,0.0001125096,0.0003801395,0.00002237253,0.007006544],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002377952,"threshold_uncertainty_score":0.007955074,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3592725044069848,"score_gpt":0.4789353361507858,"score_spread":0.119662831743801,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}